Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

• Main Authors: De Groot, S, Sleijfer, S, Redekop, W.K, Oosterwijk, E, Haanen, J.B.A.G, Kiemeney, L.A.L.M, Uyl-de Groot, C.A
• Other Authors: SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
• Format: Article
• Published: 2020
• Subjects: alpha interferon; bevacizumab; everolimus; pazopanib; sorafenib; sunitinib; temsirolimus; antineoplastic agent; indole derivative; pyrimidine derivative; pyrrole derivative; sulfonamide; adult; age; aged; Article; bone metastasis; brain metastasis; cancer prognosis; cancer registry; cancer survival; clinical effectiveness; clinical practice; cohort analysis; controlled study; drug use; drug utilization; female; high risk population; human; kidney carcinoma; liver metastasis; lung metastasis; major clinical study; male; metastasis; metastasis resection; molecularly targeted therapy; nephrectomy; Netherlands; number of metastatic site; oncological parameters; overall survival; survival time; systemic therapy; trend study; Carcinoma, Renal Cell; Kidney Neoplasms; middle aged; prescription; register; retrospective study; statistical model; survival analysis; treatment outcome; very elderly; young adult; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Prescriptions; Female; Humans; Indoles; Logistic Models; Male; Middle Aged; Molecular Targeted Therapy; Pyrimidines; Pyrroles; Registries; Retrospective Studies; Sulfonamides; Survival Analysis; Treatment Outcome; Young Adult
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181363
• Institution: National University of Singapore

10.1186/s12885-016-2395-x